Hospital Staff develops antibodies against COVID-19 virus as per a research.

Those affected with a mild form of Coronavirus produced antibodies that prevented reinfection – a crucial finding in the study.

As per a recent study conducted on hospital staff in north-eastern France, almost all doctors and nurses who suffered from mild forms of COVID-19 virus produced antibodies that prevented reinfection. Out of a total of 160 volunteers, everyone except one individual developed antibodies within 15 days from the start of infection, revealed a study in an early version of the findings, conducted by Institut Pasteur and university hospitals in Strasbourg. These antibodies were capable of neutralizing the virus within 41 days of developing symptoms among the staff. 

This research has revealed a crucial information regarding the COVID-19 virus, that the people who didn’t get severely ill-developed antibodies were capable of preventing reinfection of the virus.

Institut Pasteur’s Arnaud Fontanent and colleagues wrote in the paper that this research and the eventual findings supports the use of serologic testing for the diagnosis of patients who have recovered from the Covid-19 infection. The hospital staff developed neutralizing antibodies over time, 79% of the volunteers exhibited the antibodies in 20 days while after a completion of 41 days, 98% of the hospital staff detect antibodies in them.

Meanwhile, in India, health experts Professor Ashish Jha and Professor John Giesecke in an interaction with Congress leader Rahul Gandhi said that the pandemic will stay for more than a year and that aggressive testing is the only option to prevent its spread. India registered 6,378 new cases in the last 24 hours taking the nation’s tally to 151,767 cases and death toll rose to 4337 said the Union Health Ministry.